|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.610 CNY | +3.44% |
|
+14.60% | -9.30% |
| Market Cap | 2.66B 393M 343M 317M 291M 551M 37.83B 561M 3.78B 1.49B 18.47B 1.47B 1.44B 63.77B | P/E 2024 |
-8.86x | P/E 2025 | -9.48x |
|---|---|---|---|---|---|
| Enterprise Value | 2.88B 425M 371M 343M 315M 596M 40.91B 606M 4.09B 1.61B 19.98B 1.59B 1.56B 68.98B | EV / Sales 2024 |
1.48x | EV / Sales 2025 | 1.79x |
| Free-Float |
68.56% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | +3.44% | ||
| 1 week | +14.60% | ||
| Current month | +21.55% | ||
| 1 month | +11.42% | ||
| 3 months | -22.86% | ||
| 6 months | -11.30% | ||
| Current year | -9.30% |
| 1 week | 3.31 |  | 3.64 |
| 1 month | 2.85 | | 3.64 |
| Current year | 2.85 | | 5.27 |
| 1 year | 2.85 | | 5.27 |
| 3 years | 2.76 | | 6.15 |
| 5 years | 2.76 | | 8.8 |
| 10 years | 2.76 | | 20.3 |
| Manager | Title | Age | Since |
|---|---|---|---|
Ya Qi Dou
CEO | Chief Executive Officer | 42 | 2021-05-12 |
Xianti Zeng
DFI | Director of Finance/CFO | 52 | 2024-09-05 |
Zhi Wei Wang
PRN | Corporate Officer/Principal | 56 | 2019-09-16 |
| Director | Title | Age | Since |
|---|---|---|---|
Qi Ling Dou
CHM | Chairman | 66 | 2009-01-21 |
Zhi Wei Wang
BRD | Director/Board Member | 56 | 2011-02-20 |
Ya Qi Dou
BRD | Director/Board Member | 42 | 2019-01-02 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +3.44% | +14.60% | -12.59% | -30.98% | 418M | |
| +0.83% | -1.08% | +54.40% | +162.96% | 1,043B | |
| +2.03% | -0.69% | +56.58% | +60.43% | 602B | |
| +1.78% | +4.99% | +36.08% | +93.17% | 449B | |
| +0.95% | -0.56% | +30.23% | +24.79% | 327B | |
| +1.25% | +0.69% | +34.07% | +47.36% | 279B | |
| -0.29% | -1.54% | +22.54% | +23.88% | 264B | |
| +1.19% | +3.93% | +26.63% | +65.77% | 201B | |
| +2.09% | +7.80% | +28.64% | +80.63% | 169B | |
| +1.01% | +5.90% | +4.13% | -28.63% | 143B | |
| Average | +1.51% | +0.26% | +28.07% | +49.94% | 347.75B | |
| Weighted average by Cap. | +1.31% | -1.81% | +41.15% | +85.84% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 2.17B 321M 281M 259M 238M 451M 30.93B 458M 3.09B 1.22B 15.1B 1.21B 1.18B 52.14B | 1.86B 275M 240M 222M 204M 386M 26.5B 393M 2.65B 1.04B 12.94B 1.03B 1.01B 44.68B |
| Net income | -317M -46.83M -40.93M -37.86M -34.74M -65.74M -4.51B -66.89M -451M -177M -2.2B -176M -172M -7.61B | -330M -48.65M -42.53M -39.33M -36.09M -68.3M -4.69B -69.49M -469M -184M -2.29B -183M -179M -7.9B |
| Net Debt | 411M 60.66M 53.02M 49.03M 44.99M 85.16M 5.84B 86.64M 585M 230M 2.85B 228M 223M 9.85B | 217M 32.05M 28.02M 25.91M 23.77M 45M 3.09B 45.78M 309M 121M 1.51B 120M 118M 5.21B |
Employees
4,832
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-16 | CN¥3.610 | +3.44% | 42,692,849 |
| 26-07-15 | CN¥3.490 | +0.58% | 37,168,652 |
| 26-07-14 | CN¥3.470 | +2.06% | 30,082,403 |
| 26-07-13 | CN¥3.400 | +2.41% | 36,638,176 |
| 26-07-10 | CN¥3.320 | +5.40% | 35,226,991 |
- Stock Market
- Stocks
- 600594 Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
